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Introduction
• Background:
– PD is a high-risk, complex abdominal procedure with high rates of perioperative morbidity. Prolonged hospital stay increases the risk of
debility and increases cost to patients
– Whipple Accelerated Recovery Pathway (WARP)- developed for highly
selected patients
• Limited comorbidities
• Firm pancreas texture
• Resectable disease

– Randomized Control Trial published in 2018 by Yeo et al., showed
WARP can safely decrease hospital length of stay (LOS) and time to
adjuvant therapy (TTAT) in selected PD patients without increasing
readmission risk/rates as compared to the traditional control pathway

Introduction
• Rationale:
– If WARP was so successful for low-risk patients, how well
would higher-risk patients do on the pathway compared to
the standard post-operative pathway?
– Can WARP be applied to all-risk patients undergoing PD
similarly resulting in decreased LOS, TTAT, and risk of
readmission?

Objectives
& Hypothesis
• Research Question
– Can the WARP be expanded to
WARP-eligible (WEPs) and WARPineligible patients (WIPs) undergoing
pancreaticoduodenectomy (PD) to
improve the post-operative course?

• Hypothesis
– The WARP can be expanded to all
patients undergoing PD, which
results in lowered length of stay
(LOS), post-operative complications
(POC), time to adjuvant therapy
(TTAT), and readmission rates (RR)

Approach & Results
•

Study design
– Single-institution, retrospective chart review

•

Population / study sample
– 281 patients who underwent PD between 2017-2020
• 230 (81.9%) patients had malignant etiologies
• 51 (18.1%) patients had benign etiologies
• 119 (42.3%) were WARP-eligible under the initial criteria vs. 162 (57.7%) WARP-ineligible

•

Intervention
– WARP (5 day pathway) in ALL patients vs. Jefferson’s traditional 7 day pathway

•

Outcome
– Primary endpoints: LOS, TTAT, RR, POC

•

Data source and collection
– Epic- retrospective chart review

•

Rationale for Approach
– Jefferson is a major center for PD in the region
– Access to hundreds of patients in Epic that have undergone PD

Approach & Results
• Analysis:
– Univariate/Multivariate analysis with logistic regression

• Retrospective Analysis Findings:
WARP-Eligible
(WEPs)

WARP-Ineligible
(WIPs)

P value

Post-Op
Complications
(POCs)

28 (23.5%)

73 (45.1%)

<0.05

Length of Stay
(LOS)

5 days

6 days

<0.05

Time to
Adjuvant
Therapy (TTAT)

55 days

63 days

<0.05

Readmission
Rate (RR)

12.6%

23.5%

<0.05

POCs: Delayed Gastric
Emptying (DGE) & PostOp Pancreatic Fistulas
(POPF) occurred in
higher rates in WIPs
(DGE: 10.2% vs. 26.2%,
p<0.05; POPF: 5.1% vs.
21%, p<0.05)

Conclusions
• Conclusions:

– WARP may be expanded to all-risk patients but
WIPs may benefit from some additional mitigation
strategies to help lower RRs and POC while still
minimizing LOS
– Ex:

• WEPs- WARP is acceptable, target 4-5 day LOS
• WIPs- WARP-modification: target lower RR, lower POPF,
lower DGE while minimizing LOS (5 days)

Future Directions
• Next Steps:
– Continue to analyze patients prospectively that
are on the WARP pathway post-PD
– Work to develop additional mitigation strategies
for WIPs to help lower POC, LOS, and RRs on the
WARP pathway
– Develop and pursue additional projects off of the
established database
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